DEBx Medical

28/05/2026

Next week (June 1–2), our partner in France will be attending the annual Journées d'Étude de la FHP-SMR.

FHP is Federation of Private Hospitalization and SMR is one of the specialty unions of the FHP: the national union for Medical Care and Rehabilitation.

This year’s theme, "Faites confiance aux SMR !" (Have confidence in SMR!), focuses on empowering Medical Care and Rehabilitation facilities to deliver elite, independent patient care.

Patients in rehabilitation centers (SMR clinics) often cannot progress in their physical therapy or recovery if they have a stalled chronic wound because of biofilm and infection.

DEBRICHEM@ is a non-surgical debridement agent that can be safely applied by healthcare professionals to debride the wound bed in any treatment setting. It removes biofilm, devitalized tissue and infection in a single 60 second application, reopening the pathway to healing.

This will allow SMR clinics to confidently manage complex wound beds internally, reducing the need for costly and disruptive surgical referrals.

🤝 Our French distribution partners look forward to connecting with clinic directors, healthcare executives, and medical professionals in Biarritz to discuss how we can elevate patient outcomes together.

See you there!

27/05/2026

Granulation is a biological threshold, not a continuous process.

Clinicians use granulation tissue formation as a marker of healing progression. Yet its onset often depends on resolving specific wound bed barriers such as:

🔹 Devitalised tissue
🔹 Persistent infection
🔹 Biofilm structures
🔹 Necrotic tissue
🔹 A dysregulated microenvironment impairing cell migration and angiogenesis

Once these barriers are addressed, the wound bed transitions from a chronic inflammatory state into active proliferative repair.

In a study evaluating a heterogeneous cohort of complex wounds, including VLUs, DFUs, post-traumatic lesions, and vascular and ischemic ulcers, over 92% achieved complete granulation within a mean of 36.2 days, following a single 60-second topical desiccating intervention targeting these pathological barriers.

DEBRICHEM® works through a rapid desiccating mechanism that disrupts biofilm and removes devitalised tissue — going beyond mechanical debridement to reset the conditions for healing.

Full article: https://lnkd.in/e-Nj6E7k

Chronic wounds that fail to progress despite months of treatment pose a significant challenge in clinical practice. In this study, patients with particularly large wounds (average 57.

26/05/2026

This is a multi-modal home care protocol used to treat a stubborn 3-year-old VLU.

In this protocol, DEBRIX® serves as the initial catalyst. It establishes a powerful clinical synergy across the entire treatment pathway.

It's single 60-second application rapidly disrupts biofilm and prepares the wound bed for the next phase in healing.

The treatment pathway is: DEBRIX® + Sharp Debridement + Microlyte® + Compression. Advanced diagnostics guide this process from the start: pH measurements check the downregulation of bacteria and fluorescence imaging visualizes the real-time bacterial load.

👉 Want to see exactly how these steps integrate to disrupt the chronic wound cycle?👇 Watch the full clinical demonstration.

Thanks to the specialist nurse and SAS for helping deliver this care to the patient through this protocol and videographing the whole process.

, ,

22/05/2026

Confidence intervals are the unsung heroes of clinical decision-making.

In a peer-reviewed study published in the International Journal of Molecular Sciences, DEBRICHEM® demonstrated tight 95% confidence intervals across all bacterial reductions, with no overlap with zero.

What that means in practice:
🔹 Consistent, repeatable performance across experimental setups
🔹 High-precision bacterial reduction at the wound bed
🔹 Statistical signal strong enough to support clinical trust

For clinicians, reproducibility is the bedrock of confident treatment decisions. A 60-second topical desiccating debridement step that disrupts biofilm and devitalised tissue, with data behind the mechanism.

Full article https://www.linkedin.com/pulse/single-application-biofilm-removal-compelling-evidence-from-vmabe/

Biofilm models are laboratory systems designed to simulate real-world wound conditions, allowing researchers to study biofilm behavior and evaluate treatment effectiveness. Since biofilms differ based on factors like location, moisture levels, and bacterial composition, multiple models are needed to

21/05/2026

A shoe rub. Just a shoe rub. For someone with diabetes, that's where the story may begin.

Neuropathy quietly takes pain off the table. Friction continues, the skin breaks, circulation slows, the body's defences need backup, and a callus turns into something that calls for medical care.

High-risk patterns to watch for:
🔹 Repetitive microtrauma from daily footwear friction
🔹 Tight or poorly fitting shoes that concentrate pressure
🔹 Walking barefoot, especially where it is the cultural norm
🔹 Foot deformities that redirect pressure into vulnerable zones

Once biofilm settles in, the wound bed calls for active preparation. That's where DEBRICHEM® enters. A 60-second topical desiccating debridement step clears biofilm and devitalised tissue, with selective action that respects healthy periwound skin.

Foot ulcers start small and escalate quickly. Footwear awareness paired with smart wound bed preparation changes the trajectory.

20/05/2026

What if waiting on debridement is the most expensive thing you can do for your patient?

That's the core argument from Joan-Enric Torra on the latest Innovacure InnovaTalks podcast. Recommended viewing for anyone who manages chronic wounds.

His main points, paraphrased:
🔹 We are wound-care specialists, but we look at wounds in a person, the broader picture matters
🔹 With biofilm, slow incremental approaches only postpone the lesion. Decisive intervention wins
🔹 Wounds with devitalized tissue all deserve debridement consideration
🔹 Chemical debridement offers a radical reset, eliminates bioburden, accelerates wound bed preparation
🔹 Reducing infection means reducing antibiotic use, which means reducing the AMR footprint we all carry

The conversation covers initial vs continuous debridement, patient selection criteria, and how recent advances changed pain management.

Created by Innovacure, our partner in Colombia.
YouTube: https://www.youtube.com/watch?v=wVuOBi4Srho

The podcast is available with English subtitles.

🩹 Desbridamiento: El aliado clave para una cicatrización efectiva 🩹...

19/05/2026

Most wound care happens in someone's living room. Or nursing home. Or GP clinic. Hospital wards see only a small fraction.

Community settings dominate chronic wound management. Continuous care, varied caregivers, limited specialist access, real-life constraints. In this environment, wound bed preparation becomes a practical compass.

The TIME framework gives community teams a shared language:
🔹 Tissue: cleansing, debridement, dressing choices
🔹 Infection/Inflammation: identify when biofilm-targeting steps belong
🔹 Moisture: dressing selection that supports periwound skin
🔹 Edge: proactive review when wounds stay static

Beyond TIME, the community reality has grown:
🔹 Biofilm management as routine, even in clinically quiet wounds
🔹 Social and behavioural assessment alongside the wound itself
🔹 Simplicity and reduced dressing changes that respect patient lives

TIMERS adds Regeneration and Social to capture that wider view.

Wound bed preparation in the community creates the best conditions for healing where patients live.

Full Article: https://www.linkedin.com/pulse/wound-bed-preparation-community-settings-clearing-path-healing-2ubje/

A community setting refers to any healthcare environment outside of a hospital or specialist clinic where care is delivered closer to where people live. This includes places like: Patients’ own homes, where they may receive care from community nurses, home care aides, or family caregivers.

18/05/2026

Wounds that have stalled for years can restart. Sometimes the right combination of tools is the missing piece.

A clinical protocol paired DEBRICHEM® with Negative Pressure Wound Therapy (NPWT) on chronic leg and foot ulcers unresponsive to prior care for up to 48 months. Antibiotic-free protocol throughout.

The sequence:
🔹 Step 1: DEBRICHEM® in 60 seconds, topical desiccating debridement clears biofilm and devitalised tissue
🔹 Step 2: NPWT promotes perfusion, angiogenesis, balanced wound environment
🔹 Result: All treated ulcers reached full granulation in 13.2 days on average

Wound bed preparation paves the road, NPWT drives the engine. The combination delivers granulation faster than either tool alone.

For clinicians managing wounds resistant to standard approaches, this antibiotic-sparing protocol opens a fresh option.

Full article: https://www.linkedin.com/pulse/combining-acidic-compound-npwt-debridement-granulation-leg-yzqde/

A Synergistic Approach for Rapid Granulation in Leg and Foot Ulcers Complete granulation achieved in 13.2 days on average for ulcers that persisted for on average 13 months (3-48 months).

15/05/2026

80% of Wagner III and IV DFUs reached full granulation. One application. One minute.

A clinical case series tracked patients with the most complex DFUs, wounds present for months, refractory to repeated standard care. Each one received a 60-second DEBRICHEM® application, and the wound bed responded.

The headline numbers:
🔹 80% of complex DFUs reached full granulation
🔹 Average time to granulation: 43.9 days
🔹 Single 60-second application, antibiotic-sparing, one-time intervention

For clinicians juggling Wagner III and IV cases, this reframes what's achievable in wound bed preparation.

📌 NEW WEBINAR. Managing Post-Surgical Wound Infections with Viviana Gonçalves. Join today: https://lnkd.in/dYcQzxs7

14/05/2026

Over 140 registrations in under 24 hours. For a wound care webinar. That says a lot about how real this topic is in daily clinical practice.

Surgical site infections remain one of the most common complications after surgery. When the wound opens, biofilm takes hold, and standard approaches reach their limits, clinical teams need practical options.

Viviana Gonçalves, EWMA Council Member, shares three cardiac surgery cases where a 60-second topical desiccating agent replaced the need for return to the OR. One patient, a 72-year-old man post-sternotomy with confirmed Enterococcus faecalis, went home for Christmas instead of back to the operating room.

Hans-Pieter Snels, Product Director at DEBx Medical, covers the mechanism of action and what happens to the wound culture after application.

Thursday, June 18 at 4:00 PM CEST. Real patients. Real outcomes.

Join today: https://www.linkedin.com/events/7460293771239424000/